Treatment cuts migraine days in half
A drug called erenumab can cut the number of days with migraine symptoms for 50 per cent of patients. Across the UK, an estimated 8.5 million people live with migraine and research suggests the condition is likely to impact the lives of almost 200,000 people every day. There is an urgent need for new treatment …